SHIFT Newsroom · GLOBAL
Glucagon-like Peptide-1 Receptor Agonists May Reduce Infection Risk After Knee Replacement
Research suggests that using Glucagon-like Peptide-1 receptor agonists could decrease the risk of periprosthetic joint infection following total knee arthroplasty.
Research published on Europe PMC suggests that Glucagon-like Peptide-1 receptor agonists may reduce the risk of periprosthetic joint infection following total knee arthroplasty. This finding is based on a laterality-verified propensity matched comparison.
What this means in the UK
This finding is relevant to the UK as it may impact the management and treatment of patients undergoing total knee arthroplasty, potentially reducing the risk of complications such as periprosthetic joint infection.
Known facts
- Glucagon-like Peptide-1 receptor agonist use is associated with decreased risk of periprosthetic joint infection following total knee arthroplasty.